- Home
- DTST vs ANTX Comparison
DTST vs ANTX Comparison
Compare DTST & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- ANTX
- Stock Information
- Founded
- DTST 2001
- ANTX 2017
- Country
- DTST United States
- ANTX United States
- Employees
- DTST N/A
- ANTX N/A
- Industry
- DTST EDP Services
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- ANTX Health Care
- Exchange
- DTST Nasdaq
- ANTX Nasdaq
- Market Cap
- DTST 28.2M
- ANTX 33.2M
- IPO Year
- DTST N/A
- ANTX 2022
- Fundamental
- Price
- DTST $3.41
- ANTX $1.08
- Analyst Decision
- DTST
- ANTX Buy
- Analyst Count
- DTST 0
- ANTX 3
- Target Price
- DTST N/A
- ANTX $2.00
- AVG Volume (30 Days)
- DTST 34.4K
- ANTX 351.5K
- Earning Date
- DTST 08-13-2025
- ANTX 08-12-2025
- Dividend Yield
- DTST N/A
- ANTX N/A
- EPS Growth
- DTST N/A
- ANTX N/A
- EPS
- DTST 0.02
- ANTX N/A
- Revenue
- DTST $25,219,312.00
- ANTX N/A
- Revenue This Year
- DTST $12.57
- ANTX N/A
- Revenue Next Year
- DTST $9.29
- ANTX N/A
- P/E Ratio
- DTST $142.68
- ANTX N/A
- Revenue Growth
- DTST N/A
- ANTX N/A
- 52 Week Low
- DTST $2.93
- ANTX $0.87
- 52 Week High
- DTST $6.95
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- DTST 41.10
- ANTX 43.88
- Support Level
- DTST $3.34
- ANTX $1.07
- Resistance Level
- DTST $3.48
- ANTX $1.11
- Average True Range (ATR)
- DTST 0.18
- ANTX 0.05
- MACD
- DTST -0.03
- ANTX 0.00
- Stochastic Oscillator
- DTST 21.92
- ANTX 8.33
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.